New Leaf Ventures II, L.P.

Filings by New Leaf Ventures II, L.P. span 8 companies, the busiest being Aravive, Inc., Lite Strategy, Inc. and Principia Biopharma Inc. Between 26 January 2010 and 13 August 2019, the trades on record add up to 43 filings.

On the open market, the record shows 6 purchases worth €16.1M and 16 sales worth €42.0M. Netting one side against the other leaves €25.8M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2019 to date brings no purchases and 2 sales.

Half of the purchases are above €2.5M and half below.

The latest filing, published on 15 August 2019, reports an open-market sale of €7.8M in Principia Biopharma Inc. The most recent open-market purchase was published on 20 September 2018, 2,955 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.